Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000012208-25-000014
Filing Date
2025-03-04
Accepted
2025-03-04 19:06:30
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5740
  Complete submission text file 0000012208-25-000014.txt   7855
Mailing Address 1000 ALFRED NOBEL DRIVE HERCULES CA 94547
Business Address 1000 ALFRED NOBEL DRIVE HERCULES CA 94547 5107247000
BIO-RAD LABORATORIES, INC. (Filed by) CIK: 0000012208 (see all company filings)

EIN.: 941381833 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)

Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
Oncocyte Corp (Subject) CIK: 0001642380 (see all company filings)

EIN.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-89221 | Film No.: 25707644
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)